EMEA-002362-PIP02-19-M03
      Submitted by Anonymous (not verified) on 11 June 2025 - 15:34    
  
  EMEA-002362-PIP02-19-M03
EMEA-002362-PIP02-19-M03
EMEA-001823-PIP01-15-M03
PSUSA/00001989/202408
PSUSA/00001455/202410
EMEA-002780-PIP02-20-M01
PSUSA/00010386/202410
EMEA-002486-PIP04-21-M01
EMEA-000813-PIP01-09-M01
Human medicines European public assessment report (EPAR): Dexdor, dexmedetomidine, Date of authorisation: 15/09/2011, Revision: 17, Status: Authorised
Opinion/decision on a Paediatric investigation plan (PIP): Eliquis, Apixaban, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiovascular diseases, PIP number: P/0135/2024